• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Can Yin-Chai-Xiao-Du decoction be useful of COVID-19? the mechanism research based on network pharmacology

    2020-06-29 07:57:04LuYangNingLiHaiBoHuBinYinGuoJingZhaoFengChanWangXuHuiWangHongWuWangXueChaoLuHuanTianCui
    Traditional Medicine Research 2020年4期

    Lu Yang, Ning Li, Hai-Bo Hu, Bin Yin, Guo-Jing Zhao, Feng-Chan Wang, Xu-Hui Wang, Hong-Wu Wang, Xue-Chao Lu*, Huan-Tian Cui

    Can Yin-Chai-Xiao-Du decoction be useful of COVID-19? the mechanism research based on network pharmacology

    Lu Yang1#, Ning Li2#, Hai-Bo Hu3, Bin Yin3, Guo-Jing Zhao3, Feng-Chan Wang3, Xu-Hui Wang4, Hong-Wu Wang5, Xue-Chao Lu3*, Huan-Tian Cui6*

    1Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;2First Clinical Hospital, Shandong University of Traditional Chinese Medicine, Jinan 250000, China;3Department of Pulmonary Disease in Qingdao Hospital of Traditional Chinese Medicine, Qingdao 266700, China;4College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250000, China;5College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;6Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, Qingdao 250100, China.

    : In this study, we preliminarily investigated the mechanism of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19 by the method of network pharmacology.: The potential targets and pathways of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19 were examined using network pharmacology; the ingredient and active targets of Yin-Chai-Xiao-Du decoction were collected from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform and PharmMapper databases; the COVID-19-related targets were obtained from the online Mendelian inheritance in man, GeneCards, and GeneMANIA databases; the STRING database and Cytoscape were used to build a protein-protein interaction network, and a Network Analyzer tool was used to perform topology analysis to screen for the key ingredients and targets; the ClueGO and KOBAS 3.0 databases were for the enrichment analysis of gene function (Gene Oncology) and gene pathway (Kyoto Encyclopedia of Genes and Genomes); the herb-ingredient-target-pathway network diagram was constructed by Cytoscape.: The core herbs screened by the network pharmacological analysis wereJinyinhua (), Lianqiao (), Chaihu (), Huangqin (), Yinchen (), Guanghuoxiang (), Roudoukou () and Qinghao (). A total of 293 active ingredients were screened by Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, and the key ingredients were quercetin, kaempferol, isorhamnetin, stigmasterol, beta-sitosterol, and luteolin. Yin-Chai-Xiao-Du decoction has 138 COVID-19-related targets, and the key targets were mitogen-activated protein kinase 3, interleukin-6, tumor necrosis factor, vascular endothelial growth factor A, and CC motif ligand 2. Kyoto Encyclopedia of Genes and Genomes analysis revealed 120 enriched gene pathways, and the key pathways were signaling by interleukins, immune system, cytokine signaling in the immune system, and the signaling pathways of interleukin-17, tumor necrosis factor, and relaxin.: The core herbs of Yin-Chai-Xiao-Du decoction are Jinyinhua (), Lianqiao (), Chaihu (), Huangqin (), Yinchen (), Guanghuoxiang (), Roudoukou () and Qinghao ()The key ingredients are quercetin, kaempferol, isorhamnetin, stigmasterol, and beta-sitosterol; the critical targets are luteolin, interleukin-6, mitogen-activated protein kinase 3, tumor necrosis factor, and CC motif ligand 2; and the core signaling pathways are those mediated by interleukin-17, tumor necrosis factor, and relaxin.

    Coronavirus disease 2019,,,, Cytokine Storm, Tumor necrosis factor, Interleukin-6

    Our current study explored the potential mechanisms of Yin-Chai-Xiao-Du decoction, an empirical formula of traditional Chinese medicine derived from the classic ancient prescription Gan-Lu-Xiao-Du decoction, on COVID-19 and found its core herbs

    The empirical formula Yin-Chai-Xiao-Du decoction has evolved based on the classic ancient prescription of Gan-Lu-Xiao-Du decoction, which was first mentioned in Wei Zhixiu’s() in the Qing Dynasty of China that was released in approximately 1770 C.E. Gan-Lu-Xiao-Du decoction could alleviate fever, cough and fatigue, which were the major clinical outcomes of COVID-19. However, the mechanisms of action of Yin-Chai-Xiao-Du decoction in the treatment of COVID-19 remain unclear.

    Background

    In February 2020, the World Health Organization announced the coronavirus disease 2019 (COVID-19) as a public health emergency of international concern [1], and its main manifestations are fever, dry cough, fatigue, and pharyngalgia. More so, pneumonia, acute respiratory distress syndrome, and septic shock characterized some of the severe cases [2]. According to the latest real-time statistics of the World Health Organization on April 28, 2020, there were 2,924,722 confirmed COVID-19 cases in total globally, with more than 200,000 cumulative death cases. Sadly, symptomatic and supportive treatments are the main methods for the disease as there are no specific drugs currently and the vaccines are under trials [3]. Many scholars have pinned their hopes on antiviral drugs such as redoxivir and chloroquine. Wang et al. showed that redoxivir and chloroquine have considerable antiviral effects in the COVID-19-infected African green monkey kidney cell line VeroE6 in vitro[4]. However, in a randomized clinical trial published on April 20, 2020, in Lancet, redoxivir did not improve the recovery of the COVID-19 patients or decrease mortality compared with the placebo control group [5]. In addition, there is no sufficient clinical evidence for the anti-COVID-19 effect of chloroquine. Moreover, both medications have some adverse effects.

    Multi-ingredient, multi-target, and multi-path characterized the traditional Chinese medicine compound. Network pharmacology is a regular method for investigating the mechanisms of traditional Chinese medicine for treating COVID-19. We can find the relationship between the traditional Chinese medicine decoction and diseases by constructing the ingredient-target-pathway-disease network, identifying the key targets and submodules, and collectively analyzing the biological functions of the key targets and submodules in the network. He [7] showed that the empirical formula Xuebijing injection can treat COVID-19 by regulating the key targets of tumor necrosis factor (TNF), PRKCB, and RELA, and controlling the signaling pathways of NF-κB and hypoxia inducible factor 1. The main active ingredients of the Xiaochaihu decoction can also regulate mitogen-activated protein kinase 3 (MAPK3), Th17, and other pathways; inhibit inflammation; modulate immune function; and reduce lung injury [8].

    Yin-Chai-Xiao-Du decoction is a recommended recipe for patients with severe COVID-19 by the()[11] and is derived from the ancient prescription Gan-Lu-Xiao-Du decoction. Gan-Lu-Xiao-Du decoction was first mentioned in Wei Zhixiu’s() in the Qing Dynasty that was released in approximately 1770 C.E. The prescription was composed of Huangqin (), Yinchen (), Guanghuoxiang (), Lianqiao (), Shichangpu (), Roudoukou (), Bohe (mint), Mutong (), Shegan (blackberry lily), and Chuanbeimu ().In addition, it is commonly used for treating acute infectious diseases [9]. Yin-Chai-Xiao-Du decoction has evolved based on the formula of Gan-Lu-Xiao-Du decoction. It is composed of Chaihu(), Huangqin (), Jinyinhua (), Lianqiao (), Shichangpu (), Yujin (), Guanghuoxiang (), Peilan (),Yinchen (), Roudoukou (), Danggui (), Mudanpi (), Yiyiren (), Shishangbai (), and Gancao (). In clinical application, patients with COVID-19 mainly show a low fever after the fever is reduced. Therefore,() in the original prescription is replaced by Qinghao () to subside the low fever after the fever is reduced. This study reveals the possible molecular mode of action of Yin-Chai-Xiao-Du decoction for treating COVID-19 through network pharmacology (Figure 1).

    Figure 1 The composition chart of Yin-Chai-Xiao-Du decoction

    Materials and methods

    Virtual screening of active ingredients of Yin-Chai-Xiao-Du decoction

    We searched the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (http://ibts.hkbu.edu.hk/lsp/tcmsp.php) using the keywords of,,,,,,,,,,,,,,, andto get the candidate ingredients of Yin-Chai-Xiao-Du decoction. To obtain the active ingredients of Yin-Chai-Xiao-Du decoction, these ingredients were further screened by the criteria of oral bioavailability (OB) ≥ 30% and drug-like (DL) ≥ 0.18 [10].

    Potential target prediction and gene name annotation

    The chemical ingredients of Yin-Chai-Xiao-Du decoction were entered into the PubChem database (https://pubchem.ncbi.nlm.nih.gov/) by name, and the 3D structures were identified and stored in .sdf format. These data were then uploaded to the PharmMapper platform server (http://www.lilab-ecust.cn/pharmmapper/) [11] to complete the target prediction of the chemical composition and obtain the relevant targets of the active ingredients. The UniProt database (https://www.uniprot.org/) was used to standardize the target proteins as per the active ingredients and obtain the gene names as per the targets.

    Screening of disease targets

    The online Mendelian inheritance in man database [12] (http://omim.org/) and GeneCards database [13] (https://www.genecards.org) were searched for relevant targets using the keyword “COVID-19”. Concurrently, the coexpressed gene of severe acute respiratory syndrome coronavirus 2 for the human receptor angiotensin I converting enzyme 2 (ACE2) was identified from GeneMANIA [14] (http://genemania.org/) to obtain the disease-related targets. The Venny platform (version 2.1, http://bioinfogp.cnb.csic.es/tools/venny/) was used to intersect the targets of Yin-Chai-Xiao-Du decoction and the disease and further obtain the targets for the treatment of COVID-19.

    Protein-protein interaction (PPI) network

    Via the STRING database, the PPI was formed by the intersecting targets from drug and disease, and the PPI network was constructed with Cytoscape 3.7.2 (http://www.cytoscape.org/). Then we used the MCODE plugin to perform cluster analysis of the PPI network. Proteins can hardly achieve their biological and physiological functions alone, so the similarly related groups, called protein complexes or functional modules, accomplish specific cellular tasks. MCODE [16]is a clustering algorithm that can quickly detect densely connected areas in a large-scale target network and score the correlation of targets in the module. To select highly related clusters,the parameter K-Core was set at 2, i.e., the identified module contains at least three edges.

    Gene Oncology (GO) genetic biological process analysis

    Cytoscape’s ClueGO plugin was used to perform gene function GO enrichment analysis on the clusters obtained from common targets. The ClueGO parameter: “Homo Sapiens” in the control panel and “GO biological process” in “Ontologies/Pathways” in “ClueGO Settings” were selected, and only GO entries with≤ 0.01 were shown.

    Kyoto Encyclopedia of Genes and Genomes (KEGG) gene pathway enrichment analysis

    The intersecting targets of the herb and disease were imported into the KOBAS 3.0 database (http://kobas.cbi.pku.edu.cn) for pathway analysis. Settings: “Gene Symbol” in “Type” and “Homo Sapiens” in “Species” were selected, “KEGG” was checked,≤ 0.05, and further pathway enrichment analysis was performed on the genes identified in the screen.

    Construction of “herb-ingredient-target-pathway” network

    Cytoscape 3.7.2 was used to construct a network diagram. We first developed the network and property tables of “herb-active-ingredient-key-target-path”, and then imported them into the Cytoscape for drawing. In the output result, the herb, active ingredients, targets, and pathways were shown as colored and shaped nodes. The ingredients and potential targets were connected by edges and so were the target proteins and pathways.

    Results

    Search results of the chemical constituents of Yin-Chai-Xiao-Du decoction

    A total of 1,992 active ingredients were obtained from the screening, including Chaihu () 288, Huangqin () 58, Jinyinhua () 236, Lianqiao () 150, Shichangpu () 105, Yujin () 222, Guanghuoxiang () 94, Peilan () 60, Yinchen () 53, Roudoukou () 71, Danggui () 125, Mudanpi () 55, Yiyiren () 38, Shishangbai () 30, Gancao () 280 and Qinghao () 127. Further, all the chemical constituents found were screened with OB ≥ 30% and DL ≥ 0.18, which revealed 293 active ingredients that met the screening criteria, as shown in Figure 2 and Table 1.

    Search results of the targets of the active ingredients

    The names of the active ingredients identified by the screen were entered into the PubChem database, and the obtained structures of the ingredients were imported into the PharmMapper to predict the targets. A total of 3,758 targets were obtained, whereas 168 targets remained after deduplication. Table 1 shows the ingredients, active ingredients, and targets of herbs identified in the search and screen.

    Searching for disease genes and screening of key targets

    We obtained 1,196 COVID-19 targets from the online Mendelian inheritance in man database, 251 COVID-19 targets from the GeneCards database, and 5,556 ACE2 coexpressed genes from the GeneMANIA. Then, by intersecting the targets of the active ingredients of the herbs with the disease targets, we finally obtained 138 possible targets as per the treatment of fever by Yin-Chai-Xiao-Du decoction. Cytoscape was used to construct the target interaction network of Yin-Chai-Xiao-Du decoction, including 138 nodes and 2,640 edges in the model. The target network model is characterized as the average degree of node connection of 23, the clustering coefficient of 0.554, and the network density of the topological structure of 0.355. As shown in Figure 3 the darker the color and the larger the size, the denser the targets are. Accordingly, interleukin (IL)-6, MAPK3, JUN, TNF, VEGFA, and CC motif ligand 2 (CCL2) had higher degrees and stronger interactions with other proteins (Figure 3).

    Further cluster analysis of 138 nodes was conducted using the MCODE plugin, and six clusters were obtained (Figure 4). An analysis of the biological functions (GO) of the clusters using ClueGO plugin showed that the mechanisms were related to smooth muscle adaptation, positive regulation of cyclase activity, regulation of protein deacetylation, regulation of muscle cell apoptotic process, response to reactive oxygen species, cellular response to chemical stress, and cellular response to oxidative stress, etc.

    Results of KEGG gene pathway enrichment analysis

    Using the KOBAS 3.0 database, 120 enriched pathways were detected and the top 20 were chosen as per the-value. The results showed that the targets were remarkably enriched pathways in terms of multiple signaling pathways of ILs, immune system, cytokine in the immune system, neuroactive ligand-receptor interaction, IL-17, TNF, and relaxin (Figure 5).

    Figure 2 The number of main chemical constituents of each herb in Yin-Chai-Xiao-Du decoction

    Table 1 The number of targets of chemical constituents in Yin-Chai-Xiao-Du decoction

    Figure 3 PPI map of common targets. Each node represents a target. The darker color and larger size indicate a higher degree of nodes, which are more possible to be key targets. The proteins with higher degrees include MAPK3, JUN, TP53, IL-6, TNF, VEGFA, CCL2, and EGF, which all have stronger interactions with other proteins.

    Figure 4 The six clusters in the target network of Yin-Chai-Xiao-Du decoction. Each node represents a target and each edge represents an interaction relationship. The highly correlated nodes are enriched into a subcluster. The darker the color and the larger the size of the node, the higher its degree value is. Each cluster contains at least three edges.

    Figure 5 KEGG enrichment analysis of the targets of Yin-Chai-Xiao-Du decoction. The abscissa is the negative logarithm of the-value, and a longer band means a higher correlation; the ordinate is the name of the KEGG pathway.

    Construction of the herb-ingredient-target-pathway network

    A table of “herb-ingredient-target-pathway” network was developed and imported into Cytoscape 3.7.2 software. The red triangle nodes represent drugs, blue rectangle nodes represent pathways, and green ellipse nodes represent active ingredients. The herb-ingredient-target-pathway of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19 was constructed by the targets with orange rectangle nodes. As shown in the figure, each active ingredient acted on multiple targets. The more connected nodes and the higher correlations, the more likely it is a key ingredient, and it is then at a core position in the mechanisms of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19. After the network analysis, we found that quercetin, kaempferol, isorhamnetin, stigmasterol, beta-sitosterol, and luteolin were the top-ranked core ingredients (Figure 6).

    We selected the ingredients of the top-ranked 10 targets, and the herb-ingredient network constructed by Cytoscape showed that the ingredients with the highest degrees were quercetin, kaempferol, isorhamnetin, stigmasterol, beta-sitosterol, and luteolin. Among them, quercetin and kaempferol were shared by Jinyinhua (), Lianqiao (), Chaihu (), and Qinghao (); stigmasterol and isorhamnetin were shared by Chaihu (), Huangqin () and Qinghao (); luteolin and beta-sitosterol were shared by Jinyinhua () and Lianqiao (); quercetin and isorhamnetin were shared by Yinchen () and Guanghuoxiang (); luteolin and quercetin were shared by Roudoukou () and Lianqiao (). These data suggest that Jinyinhua (), Lianqiao (), Chaihu (), Huangqin (), Guanghuoxiang (), Yinchen (), Roudoukou (), and Qinghao () are the core herbs of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19 (Figure 7).

    Figure 6 Herb-compound-target-pathway network. The red triangle nodes represent herbs, blue rectangle nodes represent pathways, green ellipse nodes represent active ingredients, and orange rectangle nodes represent targets.

    Figure 7 Herb-top 10 ingredients network of Yin-Chai-Xiao-Du decoction. The green nodes represent the herbs, and the blue nodes represent the core ingredients.

    Discussion

    Yin-Chai-Xiao-Du decoction consists of Chaihu (), Huangqin (), Jinyinhua (),Lianqiao (), Shichangpu (), Yujin (), Guanghuoxiang (), Peilan (), Yinchen (), Roudoukou (), Danggui (), Mudanpi (), Yiyiren (), Shishangbai (), Gancao () and Qinghao (). The network pharmacology analysis showed that the key ingredients of Yin-Chai-Xiao-Du decoction for treating COVID-19 are shared by many herbs. For example, stigmasterol and isorhamnetin are shared by Chaihu () and Huangqin (). Stigmasterol shows good anti-inflammatory activity by considerably reducing the expression of IL-1β, IL-6, MCP-1, and COX-2 [17], and synergistic isorhamnetin can inhibit oxidative stress caused by inflammation [18]. Kaempferol is shared by Jinyinhua () andLianqiao (). Kaempferol can scavenge oxygen-free radicals and reduce tissue damage caused by hypoxia [19], and inhibit the expression of the TNF-α and IL-6 inflammatory factors by attenuating the activity of MAPK and AKT pathways, thereby exerting an anti-inflammatory effect [20]. Luteolin and beta-sitosterol are shared by Roudoukou () and Qinghao (). Luteolin can reduce the activity of catalase and superoxide dismutase in lung tissue, thereby reducing the level of oxidative damage and lipid peroxidation and further alleviating acute lung injury in mice [21]. Besides, it can also enhance acute lung injury by inhibiting the MEK/ERK and PI3K/Akt pathways and weakening the activation of neutrophils [22]. Beta-sitosterol has a certain protective effect on acute lung injury caused by lipopolysaccharide. It can improve the oxidative stress response and inhibit the accumulation and release of TNF-α inflammatory factors [23]. In addition, it can also inhibit the infiltration of neutrophils into tissues, reduce the production of β-glucuronidase and superoxide, regulate the complement system, and further regulate immunity system [24]. Furthermore, quercetin is shared by Yinchen () andGuanghuoxiang (). It has the effects of reducing lung inflammation and having antioxidant and antiviral effects. Other studies have shown that it can reduce the expression of TGF-β1, α-SMA, and TNF-α, inhibit the apoptosis of rat alveolar cells, and reduce the inflammation and fibrosis injury of rat lung tissue. Meanwhile, it can enhance pulmonary fibrosis by inhibiting the signal pathway of SphK1/S1P [25–27]. These two effects are synergistic. Jinyinhua (),Lianqiao (), Chaihu (),Huangqin (), Guanghuoxiang (), Yinchen (), Shishangbai (), and Qinghao () are the core herbs for the Yin-Chai-Xiao-Du decoction that have anti-inflammatory, antioxidant, immunoregulation, and lung injury improvement effects.

    Using network pharmacology to screen ingredients, predict targets, and analyze the protein network, we found that the active ingredients of Yin-Chai-Xiao-Du decoction could act on MAPK3, IL6, VEGFA, TNF, and CCL2, which are at the center of the network for treating COVID-19. The network topology analysis showed that the treatment of COVID-19 by Yin-Chai-Xiao-Du decoction involved multiple gene functions and was very complex.

    After the coronavirus invades the lung cells and infects the human body by binding with the S protein on the envelope to the ACE2 receptor [28], it is recognized by the host cell. Subsequently, the body regulates different molecular signaling pathways such as the NF-κB pathway and the MAPK/JNK pathway to trigger inflammation, resulting in the expression of proinflammatory factors and antiviral genes [29–30]. More so, activated immune cells release a large number of cytokines and chemokines, including TNF-α, interleukins (IL-1, IL-6, and IL-12), and chemokines (CCLs), leading to the initiation of inflammatory cytokine storms, which promote the transfer of immune cells to the primary infection site [31]. Then, leukocytes and lymphocytes are recruited and attracted by the boosted cytokines and chemokines to the lesion sites. They are continuously activated and proliferated in attempting to eliminate the virus by releasing inflammatory mediators [32]. Several immune cells and tissue fluids gather in the lungs to regulate the key genes, such as vascular endothelial growth factor, which changes the permeability of the blood vessel and leads to airway obstruction, lung inflammation, and edema. The patient will experience critical conditions such as extreme difficulty in breathing, blood oxygen desaturation, unconsciousness that further leads to multiple organ failure and even death [33]. Therefore, it is speculated that COVID-19 may activate the IL receptor and the MAPK pathway, increase the expression of inflammatory cytokines such as TNF-α and IL-6, and incur a local inflammatory response, therefore resulting in cytokine storms and immune disorders. Yin-Chai-Xiao-Du decoction may play an anti-inflammatory role by inhibiting these proinflammatory cytokines. It can modulate immune functions by influencing the number of immune cells and prevent multiple organ failures caused by endogenous inflammatory mediators to reduce lung damage.

    Meanwhile, COVID-19 patients have congestion and edema of the respiratory tract mucosa caused by a large number of inflammatory cell infiltration, angiectasis, and increased exudation. The large quantity of mucus secretion can be retained in the bronchus and block the normal function of tracheal smooth muscle, producing symptoms of cough, expectoration, and asthma [34]. GO enrichment analysis showed that the targets of Yin-Chai-Xiao-Du decoction were remarkably enriched in the biological processes of smooth muscle adaptation, cell response to reactive oxygen species, and cellular response to chemical stress.

    KEGG enrichment showed that the treatment of COVID-19 by Yin-Chai-Xiao-Du decoction involved multiple pathways such as the anti-inflammatory and immune regulation pathways of IL-17 and TNF. Via corresponding receptors, the IL-17 family transmits signals to activate downstream pathways such as NF-κB and MAPKs. The IL-17 family can induce the expression of antibacterial peptides, cytokines, and chemokines, which plays a vital role in acute and chronic inflammatory reactions [35]. The TNF signaling pathway mainly acts on inhibiting the cytokines in the immune response and inflammatory storm activated by COVID-19, alleviating the immune response, and eliminating the inflammation. TNF can bind to the recombinant human type I TNFR1 and TNFR2, which further mediate inflammation and immune regulation via the cascade reaction of the NF-κB pathway and MAPK [36].

    Furthermore, the KEGG results showed that the core targets were enriched in the relaxin signaling pathway, which acts on COVID-19 mainly through the following four aspects. First, severe COVID-19 cases in the recovery stage can have pulmonary fibrosis for a long time. Specifically, cases with acute respiratory distress syndrome have a poorer prognosis [37]. Mou et al. [38] examined the lung CT of 24 patients with COVID-19. They found that the lesions began to be absorbed and showed fibrosis on the lung CT of the severe and critical patients. Relaxin has anti-fibrotic effects, which have been validated in non-germinal tissue, such as the lung, heart, kidney, and liver tissue [39]. Secondly, relaxin can promote the regeneration of muscle fibers by inhibiting inflammation and fibrosis and participate in the healing of injured ligaments and skeletal muscles [40]. Most patients with COVID-19 are complicated with a concurrent condition of myalgia, which can be relieved by relaxin. More so, clinical studies have shown that the levels of serum myocardial necrosis markers increased regardless of the patient’s condition [41], indicating that COVID-19 may damage cardiac muscle cells. Experiments showed that relaxin could effectively prevent and reverse many adverse reactions in cardiovascular animal models (ischemic/reperfusion injury, myocardial infarction, hypertensive heart disease, and cardiomyopathy), and serelaxin, a recombinant form of relaxin, is in the extended phase III clinical trial for acute heart failure [42]. Finally, Jordan et al. [43] have confirmed that relaxin can prevent the death of brain cells under hypoxia conditions and may have a direct protective effect on nerves, which help to protect the brain tissue of patients with COVID-19 under hypoxia.

    Interestingly, in this network pharmacology study, chlorogenic acid and saikoside were not selected for subsequent analysis because of the low OB value (chlorogenic acid: 11.93% vs. screen criteria: OB ≥ 30) and low DL value (saikoside: 0.09 vs. screen criteria: DL ≥ 0.18). Besides, baicalein and artemisinin were not selected for subsequent analysis because their numbers of targets were 33 and 28, respectively, and ranked 17 and 44, respectively, among all ingredients. Nevertheless, more pharmacological evidence has shown that these ingredients also have anti-inflammatory, antiviral, and immunity regulation effects [44–51]; however, their values for COVID-19 treatment need to be further studied.

    Conclusion

    In summary, the core herbs of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19 are Jinyinhua (), Lianqiao (), Chaihu (), Huangqin (), Yinchen (), Guanghuoxiang (), Roudoukou (), and Qinghao (). The key ingredients include quercetin, kaempferol, isorhamnetin, stigmasterol, beta-sitosterol, and luteolin. The core targets are IL-6, MAPK3, TNF, CCL2, and the core signaling pathways are those of IL-17, TNF, and relaxin.

    1. The World Health Organization has called the 2019-ncov outbreak a public health emergency of international concern. China Health Law 2020, 2802: 34. (Chinese)

    2. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020, 323: 1061–1069.

    3. Li XS, Zhang JX, Zhou XB, et al. Literature review of existing evidence for corona virus disease-19. Eval Anal Drug Use Hosp China 2020, 03: 262–267. (Chinese)

    4. Wang ML, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020, 30: 269–271.

    5. Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2020, 395: 1569–1578.

    6. Chen YT, Sun JK, Han QY, et al. Advances of studies on remdesivir against coronavirus including SARS-CoV-2. Clin Res Prac 2020, 5: 6–11. (Chinese)

    7. He TM, Duan CC, Li XF, et al. Potential mechanism of Xuebijing injection in treatment of coronavirus pneumonia based on network pharmacology and molecular docking. Chin J Mod Appl Pharm 2020, 37: 398–405. (Chinese)

    8. Yang L, Cui HT, Liu XG, et al. Feasibility of Xiaochaihu decoction on fever induced by coronavirus disease 2019 (COVID-19) based on network pharmacology. Chin Tradit Herb Drugs 2020, 51: 1761–1775. (Chinese)

    9. Li QM. Examples of clinical application of Gan-Lu-Xiao-Du-Dan. Zhejiang J Integr Tradit Chin Western Med 2018, 09: 790–791. (Chinese)

    10. Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 2014, 6: 13.

    11. Xue J, Shi Y, Li C, et al. Network pharmacology-based prediction of the active ingredients, potential targets, and signaling pathways in compound Lian-Ge granules for treatment of diabetes. J Cell Biochem 2019, 120: 6431–6440.

    12. Obi LG, Malachi G. OMIM (online Mendelian inheritance in man). Dictionary of Bioinformatics and Computational Biology. John Wiley & Sons Ltd., 2014.

    13. Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics 2016, 54.

    14. David WF, Donaldson SL, Ovi C, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 2010, 38: W214–220.

    15. Szklarcayk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 2019, 47: D607.

    16. Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 2003, 4: 2.

    17. Feng SM, Ning K, Shao P, et al. Study on the treatment of acute colitis in mice by pitt-sitosterol and pitosterol. J Chin Cereal Oil Assoc 2018, 33: 80–86, 94. (Chinese)

    18. Wang K, Pang H, Liang CM, et al. Effects of different doses of isorhametin on proliferation of macrophage RAW264.7 in mice with inflammatory injury. Shandong Med J 2018, 39: 48–51. (Chinese)

    19. Lei XQ, Chen A, Liu Y, et al. Research progress on the pharmacological action of kaempferol. Stud Trace Elem Health 2017, 34: 61–62. (Chinese)

    20. Zhou Y, Du BY, Tan YH, et al. Inhibitory effect of kaempferol on proliferation and apoptosis of rat hepatocellular carcinoma cell CBRH7919. J Guangzhou Univ Tradit Chin Med 2010, 27: 250–253. (Chinese)

    21. Kuo MY, Liao MF, Chen FL, et al. Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and inhibition of MAPK and NF-kappaB pathways in mice with endotoxin-induced acute lung injury. Food Chem Toxicol 2011, 49: 2660–2666.

    22. Lee JP, Li YC, Chen HY, et al. Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils. Acta Pharmacol Sin 2010, 31: 831–838.

    23. Shang ZB, Liu XL, Cheng RQ, et al. Influence of β-sitosterol on gastric mucosal side effect induced by aspirin and its pharmacological functions. Chin J Exp Tradit Med Formul 2016, 22: 148–152. (Chinese)

    24. Navarro A, De LH, Villar A. Anti-inflammatory and immunomodulating properties of a sterol fraction fromfoetens clem. Biol Pharm Bull 2001, 24: 470–473.

    25. Ma N, Li YJ, Fan JP, et al. Research progress on pharmacological action of quercetin. J Liaoning Univ Tradit Chin Med 2018, 20: 221–224. (Chinese)

    26. Wei P, Chen ZB, Wang CE, et al. Protective function and mechanism of quercetin in chronic obstructive pulmonary disease. Chin J Immunol 2019, 35: 2570–2575. (Chinese)

    27. Zhang X, Cai Y, Zhang W, et al. Quercetin ameliorates pulmonary fibrosis by inhibiting SphK1/S1P signaling. Biochem Cell Biol 2018, 96: 742–751.

    28. Zhou P, Yang XL, Wang XG, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. Bio Rxiv 2020, 1.

    29. Wang JF, Shao JJ, Chang HY, et al. Advances in research on innate immune recognition receptors of viruses. Chin J Cell Mol Immunol 2009, 25: 1217–1220. (Chinese)

    30. Chow KT, Gale M, Loo YM. RIG-I and other RNAsensors in antiviral immunity. Annual Rev Immunol 2018, 36: 667–694.

    31. Mc NF, Mayer-Barber KD, Sher A, et al. Type I interferons in infectious disease. Nat Rev Immunol 2015, 15: 87–103.

    32. Teijaro JR. Cytokine storms in infectious diseases. Semin Immunopathol 2017, 39: 501–503.

    33. Clark IA,Vissel B. The meteorology of cytokine storms, and the clinical usefulness of this knowledge. Semin Immunopathol 2017, 39: 505–516.

    34. Mejza F, Gnatiuc L, Buist AS, et al. Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study. Eur Respir J 2017, 50: 1700621.

    35. Li XX, Bechara R, Zhao JJ, et al. IL-17 receptor-based signaling and implications for disease. Nat Immunol 2019, 20: 1594–1602.

    36. Zhang Y, Zhou DM, Li W, et al. The expression level of TNF-α in patients with painful diabetic neuropathy. Chin J Lab Diagn 2020, 24: 36–40. (Chinese)

    37. Respiratory Disease Committee of Shanghai Association of Integrative Medicine. Suggestions of integrative medicine treatment on some hot issues about COVID-19. Shanghai J Tradit Chin Med 2020, 54: 6–9. (Chinese)

    38. Mu J, Wang RP, Liu XF, et al. Preliminary discussion for chest CT dynamic findings of COVID-19 patients. Chin Imaging J Integr Tradit Western Med 2020, 18: 116–119. (Chinese)

    39. Samuel CS, Royce SG, Hewitson TD, et al. Anti-fibrotic actions of relaxin. Br J Pharmacol 2017, 174: 962–976.

    40. Dehghan F, Haerian BS, Muniandy S, et al. The effect of relaxin on the musculoskeletal system. Scand J Med Sci Sports 2014, 24: e220–e229.

    41. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020, 323: 1061–1069.

    42. Sarwar M, Du XJ, Dschietzig TB, et al. The actions of relaxin on the human cardiovascular system. Br J Pharmacol 2017, 174: 933–949.

    43. Willcox JM, Summerlee AJ. Relaxin protects astrocytes from hypoxia in vitro. PLoS One 2014, 9: e90864.

    44. Huang L, Tang JL, Huang J, et al. Advances in extraction and application of chlorogenic acid. Res Lab Work Coll Univ 2012, 9: 114–117. (Chinese)

    45. Wu HZ, Luo J, Yin YX, et al. Effects of chlorogeni acid, an active compound activating calcineurin, purified fromon macrophage. Acta Pharmacol Sin 2004, 25: 1685–1689.

    46. Zhu J, Luo C, Wang P, et al. Saikosaponin a mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells. Exp Ther Med 2013, 5: 1345–1350.

    47. Wan QF, Gu LG, Yin SJ, et al. Protection effect of baicalin on lung injury of mice infected with influenza FM1. China J Tradit Chin Med Pharm 2011, 26: 2818–2851. (Chinese)

    48. Wan QF, Wang H, Han XB, et al. Baicalin inhibits TLR7/MYD88 signaling pathway activation to suppress lung inflammation in mice infected with influenza a virus. Biomed Rep 2014, 2: 437–441.

    49. Wang JX, Tang W, Yang ZS, et al. Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo. Eur J Pharmacol 2007, 564: 211–218.

    50. Khakzad MR, Ganji A, Ariabod V, et al. Artemisinin therapeutic efficacy in the experimental model of multiple sclerosis. Immunopharmacol Immunotoxicol 2017, 39: 348–353.

    51. Wen Y, Pan MM, Lv LL, et al. Artemisinin attenuates tubulointerstitial inflammation and fibrosis via the NF-κB/NLRP3 pathway in rats with 5/6 subtotal nephrectomy. J Cell Biochem 2019, 120: 4291–4300.

    :

    Lu Yang and Ning Li contributed to study concept; Hai-Bo Hu and Bin Yin contributed to study design and performance; Guo-Jing Zhao, Feng-Chan Wang and Xu-Hui Wang contributed to analysis of data; Hong-Wu Wang, Lu Yang and Ning Li contributed to drafting of the paper; Xue-Chao Lu and Huan-Tian Cui contributed to study supervision.

    :

    The authors declare no conflicts of interest.

    :

    This study was supported bythe National Key Research and Development Program (No. 2018YFC1704800) and the Chinese Medicine Standardization Project of State Administration of Traditional Chinese Medicine (No. SATCM-2015-BZ125).

    :

    COVID-19, coronavirus disease 2019; TNF, tumor necrosis factor; OB, oral bioavailability; DL, drug-like; GO, Gene Oncology; KEGG, Kyoto Encyclopedia of Genes and Genomes; MAPK3, mitogen-activated protein kinase 3; ACE2, angiotensin I converting enzyme 2; IL, interleukin; PPI, protein-protein interaction; CCL2, CC motif ligand 2.

    :

    Lu Yang, Ning Li, Hai-Bo Hu, et al. Can Yin-Chai-Xiao-Du decoction be useful of COVID-19? the mechanism research based on network pharmacology. Traditional Medicine Research 2020, 5 (4): 188–200.

    :Rui-Wang Zhao.

    :13 May 2020,

    28 May 2020,

    :09 June 2020.

    #These authors are co-first authors on this work.

    Xue-Chao Lu. Department of Pulmonary Disease in Qingdao Hospital of Traditional Chinese Medicine, No.4 Renmin Road, North District, Qingdao 266700, China. E-mail: hospitalbreathing@163.com; Huan-Tian Cui. Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, No.72 Binhai Road, Jimo District, Qingdao 250100, China. E-mail: 1762316411@qq.com.

    10.12032/TMR20200601185

    成人欧美大片| 尤物成人国产欧美一区二区三区| 国产免费一区二区三区四区乱码| 亚洲av电影在线观看一区二区三区 | 91久久精品电影网| 97超碰精品成人国产| 搡女人真爽免费视频火全软件| 日产精品乱码卡一卡2卡三| 国产精品国产三级专区第一集| 少妇被粗大猛烈的视频| 搡女人真爽免费视频火全软件| 亚洲精品色激情综合| 18禁在线播放成人免费| av一本久久久久| 亚洲av一区综合| 最后的刺客免费高清国语| 日韩 亚洲 欧美在线| 狂野欧美白嫩少妇大欣赏| 直男gayav资源| 少妇熟女欧美另类| 国产亚洲午夜精品一区二区久久 | 日韩成人av中文字幕在线观看| 在线观看免费高清a一片| 免费观看的影片在线观看| 狂野欧美白嫩少妇大欣赏| 免费黄频网站在线观看国产| 免费看不卡的av| 五月开心婷婷网| 1000部很黄的大片| 欧美日韩在线观看h| 日日撸夜夜添| 国产一区二区亚洲精品在线观看| 综合色av麻豆| 一区二区三区乱码不卡18| 久久精品国产亚洲网站| 国产色爽女视频免费观看| 亚洲人成网站在线观看播放| 亚洲精品日韩在线中文字幕| 午夜激情久久久久久久| 在线免费观看不下载黄p国产| 联通29元200g的流量卡| 久久久午夜欧美精品| 91久久精品国产一区二区三区| 人妻少妇偷人精品九色| 成人综合一区亚洲| 亚洲第一区二区三区不卡| 日韩大片免费观看网站| 禁无遮挡网站| 一级爰片在线观看| 国产永久视频网站| 深爱激情五月婷婷| 亚洲成人一二三区av| 亚洲性久久影院| 国产精品成人在线| 免费大片18禁| 干丝袜人妻中文字幕| 久久精品国产亚洲av涩爱| 亚洲欧美精品专区久久| 一区二区三区四区激情视频| videos熟女内射| 国产老妇女一区| 99久久中文字幕三级久久日本| 国语对白做爰xxxⅹ性视频网站| av黄色大香蕉| 在线天堂最新版资源| 一本色道久久久久久精品综合| 99久久精品国产国产毛片| 亚洲精品一区蜜桃| 三级国产精品欧美在线观看| 舔av片在线| 三级国产精品片| 亚洲精品一二三| 蜜臀久久99精品久久宅男| 18禁在线播放成人免费| 成年av动漫网址| 伦理电影大哥的女人| 久久精品久久久久久噜噜老黄| 女人十人毛片免费观看3o分钟| 蜜桃久久精品国产亚洲av| 成人免费观看视频高清| 亚洲美女视频黄频| 国产精品久久久久久精品电影小说 | 波多野结衣巨乳人妻| freevideosex欧美| 狂野欧美激情性xxxx在线观看| 观看美女的网站| 亚洲av中文字字幕乱码综合| 80岁老熟妇乱子伦牲交| 国产成人精品一,二区| 涩涩av久久男人的天堂| 精品99又大又爽又粗少妇毛片| 在线亚洲精品国产二区图片欧美 | 国产成人午夜福利电影在线观看| 亚洲经典国产精华液单| 久久久午夜欧美精品| 一级毛片 在线播放| 观看美女的网站| 狂野欧美激情性bbbbbb| videos熟女内射| 在线精品无人区一区二区三 | 成年女人看的毛片在线观看| 久久ye,这里只有精品| 天堂俺去俺来也www色官网| 欧美+日韩+精品| 国产一区二区在线观看日韩| 亚洲高清免费不卡视频| 日本一本二区三区精品| 日产精品乱码卡一卡2卡三| 日本爱情动作片www.在线观看| 国产爽快片一区二区三区| 看十八女毛片水多多多| xxx大片免费视频| 黄色视频在线播放观看不卡| 亚洲欧美成人精品一区二区| 亚洲怡红院男人天堂| 春色校园在线视频观看| 亚洲国产精品999| 精华霜和精华液先用哪个| 一二三四中文在线观看免费高清| 国产成人精品一,二区| 精品人妻偷拍中文字幕| 久久97久久精品| 精品亚洲乱码少妇综合久久| 91午夜精品亚洲一区二区三区| 一级a做视频免费观看| 亚洲精品成人av观看孕妇| 伦精品一区二区三区| 26uuu在线亚洲综合色| 精品久久久精品久久久| 97超碰精品成人国产| 美女主播在线视频| 丝袜脚勾引网站| 午夜免费男女啪啪视频观看| 国产亚洲5aaaaa淫片| 久久99热这里只频精品6学生| 九九爱精品视频在线观看| 人体艺术视频欧美日本| 我要看日韩黄色一级片| 亚洲国产精品国产精品| 亚洲一区二区三区欧美精品 | av.在线天堂| 男女边吃奶边做爰视频| 高清毛片免费看| 精品国产一区二区三区久久久樱花 | 亚洲精品视频女| 日韩成人av中文字幕在线观看| 久久精品国产a三级三级三级| 国产午夜福利久久久久久| 国产一区二区亚洲精品在线观看| 日本三级黄在线观看| 天堂中文最新版在线下载 | av在线app专区| 纵有疾风起免费观看全集完整版| 国产高清有码在线观看视频| 可以在线观看毛片的网站| 国产精品偷伦视频观看了| 日日摸夜夜添夜夜爱| 老女人水多毛片| 天天躁夜夜躁狠狠久久av| 天美传媒精品一区二区| 老师上课跳d突然被开到最大视频| 三级国产精品欧美在线观看| 久久人人爽av亚洲精品天堂 | 亚洲成色77777| 大片电影免费在线观看免费| 狠狠精品人妻久久久久久综合| 国产av码专区亚洲av| 精品久久国产蜜桃| 久久精品国产亚洲av天美| 1000部很黄的大片| 天天躁日日操中文字幕| 中文资源天堂在线| 亚洲精品色激情综合| a级毛色黄片| 国产精品一区二区在线观看99| 又粗又硬又长又爽又黄的视频| 美女高潮的动态| 老司机影院毛片| 国产亚洲午夜精品一区二区久久 | xxx大片免费视频| 性色av一级| 亚洲成人av在线免费| 国产成人福利小说| 又爽又黄a免费视频| 国产女主播在线喷水免费视频网站| 超碰av人人做人人爽久久| 精品亚洲乱码少妇综合久久| 日本与韩国留学比较| 丰满少妇做爰视频| 麻豆成人av视频| 免费电影在线观看免费观看| 香蕉精品网在线| 免费观看av网站的网址| 美女xxoo啪啪120秒动态图| av线在线观看网站| 中文天堂在线官网| 亚洲va在线va天堂va国产| 人人妻人人看人人澡| 国产精品秋霞免费鲁丝片| 国产精品久久久久久精品电影小说 | h日本视频在线播放| 国产成人福利小说| 国产91av在线免费观看| 男女边摸边吃奶| 色播亚洲综合网| 99久久精品一区二区三区| 久久久久精品久久久久真实原创| 麻豆精品久久久久久蜜桃| av福利片在线观看| a级毛片免费高清观看在线播放| 国产爽快片一区二区三区| 国内少妇人妻偷人精品xxx网站| 91在线精品国自产拍蜜月| 国产免费又黄又爽又色| 精品一区二区免费观看| 特大巨黑吊av在线直播| 国产黄色免费在线视频| 久久久久网色| 99精国产麻豆久久婷婷| 国产综合精华液| 久久久a久久爽久久v久久| 久久99精品国语久久久| 人妻少妇偷人精品九色| 国产老妇女一区| 偷拍熟女少妇极品色| 国产亚洲av片在线观看秒播厂| av播播在线观看一区| 一本久久精品| 99re6热这里在线精品视频| 777米奇影视久久| 在线亚洲精品国产二区图片欧美 | 亚洲精品国产av蜜桃| 在线看a的网站| 久久精品久久精品一区二区三区| kizo精华| 自拍欧美九色日韩亚洲蝌蚪91 | 欧美丝袜亚洲另类| 精品国产露脸久久av麻豆| 青春草亚洲视频在线观看| 国产大屁股一区二区在线视频| 亚洲欧美日韩无卡精品| 水蜜桃什么品种好| 制服丝袜香蕉在线| 欧美日韩国产mv在线观看视频 | 久久99蜜桃精品久久| 国产精品嫩草影院av在线观看| 国产一区二区三区综合在线观看 | 午夜激情福利司机影院| 国内精品美女久久久久久| 国精品久久久久久国模美| 日韩欧美一区视频在线观看 | 看非洲黑人一级黄片| 亚洲人与动物交配视频| 1000部很黄的大片| 亚洲最大成人手机在线| 久久久久久久久久人人人人人人| 少妇猛男粗大的猛烈进出视频 | videossex国产| 欧美人与善性xxx| 日韩av免费高清视频| 久久久久久久久久久丰满| 久久99精品国语久久久| 午夜激情福利司机影院| 久久久久久九九精品二区国产| 最后的刺客免费高清国语| 十八禁网站网址无遮挡 | 在线观看三级黄色| 99久久人妻综合| 2021天堂中文幕一二区在线观| 99久国产av精品国产电影| 网址你懂的国产日韩在线| 听说在线观看完整版免费高清| 免费少妇av软件| 免费播放大片免费观看视频在线观看| 蜜桃亚洲精品一区二区三区| 少妇人妻一区二区三区视频| 久久精品久久久久久久性| 永久免费av网站大全| 最后的刺客免费高清国语| 久久鲁丝午夜福利片| 成人特级av手机在线观看| 亚洲人成网站高清观看| 日韩大片免费观看网站| 国产久久久一区二区三区| 少妇人妻一区二区三区视频| 国产69精品久久久久777片| 成人毛片a级毛片在线播放| 欧美xxxx黑人xx丫x性爽| 天天一区二区日本电影三级| 麻豆精品久久久久久蜜桃| 制服丝袜香蕉在线| 日本欧美国产在线视频| 天堂中文最新版在线下载 | 一个人看视频在线观看www免费| 日本猛色少妇xxxxx猛交久久| 国产乱人偷精品视频| eeuss影院久久| 性色av一级| 亚洲一区二区三区欧美精品 | 免费观看a级毛片全部| 国产中年淑女户外野战色| 我的老师免费观看完整版| 亚洲国产最新在线播放| 成人亚洲欧美一区二区av| 亚洲欧美日韩卡通动漫| 岛国毛片在线播放| 免费观看无遮挡的男女| 高清视频免费观看一区二区| 欧美一区二区亚洲| 亚洲,欧美,日韩| 噜噜噜噜噜久久久久久91| 成人欧美大片| 久久久成人免费电影| 免费看日本二区| 只有这里有精品99| 51国产日韩欧美| 成人毛片60女人毛片免费| 日韩免费高清中文字幕av| h日本视频在线播放| 国产高清有码在线观看视频| 欧美激情久久久久久爽电影| 偷拍熟女少妇极品色| 人人妻人人看人人澡| 精品久久国产蜜桃| 亚洲av中文字字幕乱码综合| a级毛片免费高清观看在线播放| 男女无遮挡免费网站观看| 黑人高潮一二区| 中文在线观看免费www的网站| 一区二区av电影网| 国产乱人偷精品视频| 亚洲真实伦在线观看| 18禁在线无遮挡免费观看视频| 在线观看人妻少妇| 国产av码专区亚洲av| 亚洲内射少妇av| 欧美xxxx性猛交bbbb| 亚洲欧美日韩东京热| 丰满人妻一区二区三区视频av| 少妇人妻精品综合一区二区| 国产黄片美女视频| 中文精品一卡2卡3卡4更新| 国内精品宾馆在线| 欧美人与善性xxx| 自拍欧美九色日韩亚洲蝌蚪91 | 视频区图区小说| 国产精品久久久久久精品电影小说 | 日本黄色片子视频| 老司机影院毛片| 国产高清国产精品国产三级 | 国产在线男女| 国产精品av视频在线免费观看| 日韩 亚洲 欧美在线| 国产精品一区二区在线观看99| 欧美少妇被猛烈插入视频| 国产精品蜜桃在线观看| 亚洲欧美精品自产自拍| 日日摸夜夜添夜夜爱| 欧美变态另类bdsm刘玥| 高清日韩中文字幕在线| 久久精品国产亚洲网站| 黄色一级大片看看| 有码 亚洲区| 干丝袜人妻中文字幕| 日本免费在线观看一区| 99九九线精品视频在线观看视频| av在线app专区| 亚洲成人精品中文字幕电影| 禁无遮挡网站| 亚洲欧美日韩东京热| 亚洲内射少妇av| 免费黄网站久久成人精品| 中文字幕av成人在线电影| 免费观看无遮挡的男女| 赤兔流量卡办理| 精品久久久久久电影网| 国产视频内射| 国产精品久久久久久久电影| 精品少妇久久久久久888优播| 亚洲三级黄色毛片| 菩萨蛮人人尽说江南好唐韦庄| 美女高潮的动态| 中文字幕av成人在线电影| 啦啦啦中文免费视频观看日本| 搞女人的毛片| 国产精品久久久久久av不卡| 国产有黄有色有爽视频| 亚洲国产精品成人久久小说| 在线观看av片永久免费下载| 久久99热6这里只有精品| 亚洲成人精品中文字幕电影| 日韩一区二区三区影片| 国产午夜福利久久久久久| 观看美女的网站| 国产日韩欧美在线精品| 午夜福利在线在线| 有码 亚洲区| 欧美成人午夜免费资源| 亚洲激情五月婷婷啪啪| 性色avwww在线观看| 亚洲,欧美,日韩| 国产成人福利小说| 亚洲国产精品国产精品| 国产精品福利在线免费观看| 在线 av 中文字幕| 黄色日韩在线| 视频中文字幕在线观看| av专区在线播放| 七月丁香在线播放| 国产高清三级在线| 国产一区亚洲一区在线观看| 国产伦精品一区二区三区四那| 亚洲精品国产色婷婷电影| 尾随美女入室| 欧美zozozo另类| 亚洲av二区三区四区| 午夜老司机福利剧场| 亚洲国产高清在线一区二区三| 亚洲四区av| 久久热精品热| 男人狂女人下面高潮的视频| 国产精品av视频在线免费观看| 新久久久久国产一级毛片| 黑人高潮一二区| 久久久久久九九精品二区国产| 免费黄色在线免费观看| 精华霜和精华液先用哪个| 高清毛片免费看| 最近最新中文字幕免费大全7| 精品一区二区三卡| 成人漫画全彩无遮挡| 日韩,欧美,国产一区二区三区| 一二三四中文在线观看免费高清| 欧美日韩一区二区视频在线观看视频在线 | 在线免费十八禁| 亚洲精品久久久久久婷婷小说| 最近2019中文字幕mv第一页| 成人黄色视频免费在线看| 国产爽快片一区二区三区| 免费电影在线观看免费观看| 久久久精品免费免费高清| 一边亲一边摸免费视频| 国产亚洲最大av| 搞女人的毛片| 最后的刺客免费高清国语| 亚洲av日韩在线播放| 最近2019中文字幕mv第一页| 五月伊人婷婷丁香| 国产大屁股一区二区在线视频| 九色成人免费人妻av| 国产精品不卡视频一区二区| 国产成人a∨麻豆精品| 亚洲av二区三区四区| 亚洲四区av| 午夜日本视频在线| 99热这里只有精品一区| 亚洲国产欧美在线一区| 中文资源天堂在线| 王馨瑶露胸无遮挡在线观看| 中文天堂在线官网| 国产v大片淫在线免费观看| 亚洲怡红院男人天堂| 日韩视频在线欧美| av在线天堂中文字幕| 亚洲色图av天堂| 国产精品熟女久久久久浪| freevideosex欧美| 亚洲美女搞黄在线观看| 国产一区亚洲一区在线观看| 日日摸夜夜添夜夜添av毛片| 亚洲精品影视一区二区三区av| 夜夜看夜夜爽夜夜摸| 人妻少妇偷人精品九色| 亚洲精品成人久久久久久| 乱码一卡2卡4卡精品| 国产av不卡久久| 91精品一卡2卡3卡4卡| 在线观看免费高清a一片| 寂寞人妻少妇视频99o| 三级国产精品片| 少妇人妻 视频| 国产色婷婷99| 综合色丁香网| 亚洲国产高清在线一区二区三| 少妇 在线观看| 精品国产乱码久久久久久小说| 观看免费一级毛片| 久久影院123| 波野结衣二区三区在线| 乱系列少妇在线播放| 亚洲熟女精品中文字幕| 国产一区有黄有色的免费视频| 丰满乱子伦码专区| 成年版毛片免费区| 国产精品一区www在线观看| 国产一区二区三区av在线| videos熟女内射| 91久久精品国产一区二区三区| 国产精品一区二区三区四区免费观看| 久久久色成人| 黄片无遮挡物在线观看| 老女人水多毛片| 激情 狠狠 欧美| 久久女婷五月综合色啪小说 | 一个人看的www免费观看视频| 国产片特级美女逼逼视频| 国产真实伦视频高清在线观看| 乱码一卡2卡4卡精品| 狂野欧美激情性xxxx在线观看| 成人免费观看视频高清| 精品人妻熟女av久视频| 在线观看一区二区三区| 日韩一区二区视频免费看| 亚洲欧美日韩卡通动漫| 欧美精品一区二区大全| 91精品国产九色| 在线观看三级黄色| 天天一区二区日本电影三级| 好男人在线观看高清免费视频| 国产一区二区三区av在线| 丝袜喷水一区| 色视频在线一区二区三区| av.在线天堂| 日本黄色片子视频| 97超视频在线观看视频| 高清视频免费观看一区二区| 免费观看的影片在线观看| av播播在线观看一区| 丝袜喷水一区| 午夜免费鲁丝| 麻豆久久精品国产亚洲av| 国产精品伦人一区二区| 国产欧美另类精品又又久久亚洲欧美| 高清视频免费观看一区二区| av国产久精品久网站免费入址| 午夜福利在线观看免费完整高清在| 大香蕉97超碰在线| 亚洲欧美一区二区三区黑人 | 国产极品天堂在线| 特大巨黑吊av在线直播| 七月丁香在线播放| 一级毛片aaaaaa免费看小| 欧美一区二区亚洲| 亚洲色图av天堂| 春色校园在线视频观看| 欧美xxⅹ黑人| 国产美女午夜福利| 街头女战士在线观看网站| 久久精品国产a三级三级三级| av免费在线看不卡| 欧美一级a爱片免费观看看| a级毛片免费高清观看在线播放| 一个人看视频在线观看www免费| 亚洲av国产av综合av卡| 亚洲高清免费不卡视频| 制服丝袜香蕉在线| 99热全是精品| 久久精品久久久久久噜噜老黄| 精品人妻一区二区三区麻豆| 777米奇影视久久| 国产伦精品一区二区三区四那| 91久久精品国产一区二区三区| av在线亚洲专区| 日韩成人av中文字幕在线观看| 免费看光身美女| 国产成人免费无遮挡视频| 亚洲av二区三区四区| 国产亚洲精品久久久com| 国内少妇人妻偷人精品xxx网站| 久久久色成人| 日韩av不卡免费在线播放| 色婷婷久久久亚洲欧美| 中文字幕av成人在线电影| 女人被狂操c到高潮| 免费播放大片免费观看视频在线观看| videos熟女内射| 夫妻午夜视频| 久久久久久久久久成人| 久久韩国三级中文字幕| 一级毛片黄色毛片免费观看视频| 国产精品久久久久久精品电影小说 | 又爽又黄无遮挡网站| 草草在线视频免费看| 中文字幕久久专区| 99九九线精品视频在线观看视频| 少妇高潮的动态图| 热99国产精品久久久久久7| 午夜日本视频在线| 欧美极品一区二区三区四区| 一本色道久久久久久精品综合| 小蜜桃在线观看免费完整版高清| 视频中文字幕在线观看| 三级男女做爰猛烈吃奶摸视频| 亚洲国产色片| 亚洲欧美精品专区久久| 别揉我奶头 嗯啊视频| 777米奇影视久久| 日韩成人伦理影院| 性插视频无遮挡在线免费观看| 在线看a的网站| 国产精品伦人一区二区| 五月玫瑰六月丁香| 欧美+日韩+精品| 美女cb高潮喷水在线观看| 欧美亚洲 丝袜 人妻 在线| 99久久人妻综合| 国产精品三级大全| 亚洲欧美日韩东京热| 亚洲欧美日韩另类电影网站 | 成人国产av品久久久| 91精品伊人久久大香线蕉| 久久99精品国语久久久| 免费人成在线观看视频色| 午夜老司机福利剧场| eeuss影院久久|